ANTONIO MARÍA CABALLERO MATEOS-rekin lankidetzan egindako argitalpenak (6)

2017

  1. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  2. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  3. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  4. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  5. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217

2015

  1. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143